Integrate Risk Evaluation & Mitigation Strategies (REMS) with Health Management Craig Kephart, President & CEO Centric Health Resources, Inc. July 15,

Slides:



Advertisements
Similar presentations
Patient Centered Health Management® What we do Centric provides commercialization, distribution and Health Management services to the Ultra-orphan and.
Advertisements

Achieving Affordable and Effective Health Care Reform Karen Ignagni President & CEO April 27, 2009.
Integration of Behavioral Health Services with Primary Care Presented by: Sharon Beaty.
Pharmacy Benefit Managers (PBMs)
MEDICAL HOME 1/2009 Mary Goldman, D.O., President of MAOFP.
Company Analysis.
Providing Control, Autonomy and Profitability for the Healthcare Provider PHYSICIANS PROVISO.
Tad P. Fisher Executive Vice President Florida Academy of Family Physicians Patient Centered Medical Home A Medicaid Managed Care Alternative.
Disease State Management The Pharmacist’s Role
Patient Centered Health Management® 1 Pressure from Increases in Cost, Pricing Implications, and Launch Considerations Craig Kephart, President & CEO Centric.
The Value of Medication Therapy Management Services
REMS Update NORD Corporate Council Meeting May 14, 2013
Agenda DUKE UNIVERSITY MEDICAL CENTER Department of Psychiatry and Behavioral Sciences Clinical Research within an EMR What the difference between an EMR.
Managerial Accounting and the Business Environment Chapter 1 McGraw-Hill/Irwin Copyright © 2010 by The McGraw-Hill Companies, Inc. All rights reserved.
Informatics And The New Healthcare System Information Technology Will Provide the Platform for Quality Improvement in Healthcare for the 21 st Century.
Medication Therapy Management Linda Mach, PharmD Bartell Drugs Community Practice Resident February 26, 2010.
Industrial Organization Economists have developed a branch of economic analysis called Industrial Organization to trace the relationship between the structure.
Ambulatory care Prepared by: Nehad Ahmed. Ambulatory care is Primary care-based services and services provided from office-based specialists and hospital.
It’s A Success! Achieving Cost-Effective Disease Management in CHF Sherry Shults, RN BSN CIO South Carolina Heart Center.
1 Alvimopan RiskMAP Joyce Weaver, Pharm.D., BCPS Office of Surveillance and Epidemiology.
Who We Are We enable our customers to gain unprecedented insights to optimize their customer, channel partner, vendor and employee relationships. TheMindSuite.
PPF- Atlantic Summit on Healthcare and Drug Cost Sustainability Perry Eisenschmid CEO, Canadian Pharmacists Association October 30, 2014.
PFIZER PHARMACEUTICALS. HISTORY, CEO, BACKGROUND CEO: Ian Read Develops and produces medicines & vaccines  Lipitor  Lyrica  Celebrex  Viagra Founded.
Population Health John Studebaker, MD, MS Forward Health Group, Inc.
Pharmacy Services.
1 The Case Management Approach October 11, 2012 International Centre, Mississauga, ON Suzanne Lepage Private Health Plan Strategist.
SESIH Redesign Update Older Persons and Chronic Care Project Paul Preobrajensky Manager Redesign Program 19 September 2007.
The BIPA Disease Management Demo Project: Improving Outcomes For Medicare Beneficiaries Prepared for: Disease Management Colloquium June 29, 2004 The BIPA.
Pharmaceutical Economics Heng-Sim Lee RPh MS Director of Pharmacy, ChiaYi Branch, Taichung Veterans General Hospital Clinical Nutritional.
In Which Areas Have Clinical Pharmacists Been the Most Successful in Patient Care ? Hospital inpatient unit (wards) –Therapeutic drug monitoring –Anticoagulation.
Bryan Bray, Pharm.D., CPP Chief Operating Officer Medication Management, LLC Vice President of Clinical Services Piedmont Pharmaceutical Care Network,
The Value of Medication Therapy Management Services.
Practice Management: Tips for a Successful GI Practice James J. Weber, MD President & CEO of Texas Digestive Disease Consultants.
LDL Program Medical Management Philip E. Johnston, Pharm.D.
Clinical Pharmacy Part 2
© 2014 IBM Corporation Smarter Workforce Services Business Process Innovation.
Driving Business Value Through Back-Office Modernization Brent Maropis, CEO.
Medication Therapy Management Programs in Community Pharmacy Community Pharmacy October 17, 2006 Kurt A. Proctor, Ph.D., RPh Chief Operating Officer Community.
Pharmaceutical Company – Catamaran
Introduction.
2.1 Marketing Planning MARKETING MR. PAVONE. SWOT Analysis.
Pharmacists’ Patient Care Process
Accutane FDA (Section Name - Saver’s Initials) 3/9/00 12:50 PM 1 Risk Management Options Russell Ellison, MD Chief Medical Officer Vice President, Medical.
MedBiquitous May 15, 2008 Integrating Quality Improvement Data into a Web- based CME Activity MedBiquitous May 15, 2008 Annette D. Boyer, R.Ph. CECity.com,
Pharmaceutical Company Driven Disease Management in Medicare Part D: Opportunities and Threats Barry Patel, Pharm.D. President and Co-Founder Total Therapeutic.
Terry McInnis, MD MPH President- Blue Thorn, Inc - Mobile Co-Chair- Center for.
1 Copyright © 2009, 2006, 2003, 2000, 1997, 1994 by Saunders, an imprint of Elsevier Inc. Chapter 15 The Health Care Organization and Patterns of Nursing.
Transforming Care in Patient Centered Medical Home and Accountable Care Organization Hae Mi Choe, PharmD Director, Pharmacy Innovations & Partnerships.
Pharmacy Benefit Management (PBM) 101
Creating Customized Resident Self-Evaluation Assessments in PharmAcademic TM Andrea Weeks, PharmD PGY1 Residency Co-Director and Preceptor Paoli Hospital.
PROPRIETARY & CONFIDENTIAL 1 Specialty Pharmacy Trends and AcariaHealth Specialty Pharmacy Solution AcariaHealth Presentation April 6, 2015.
Introduction 2. Pharmaceutical care is a professional patient care practice, which, when provided as an organized service, is experienced, documented,
Developing, Pilot Testing & Evaluating RiskMAP Interventions Annette Stemhagen, DrPH, FISPE Vice President UBC Epidemiology & Risk Management The FDA Regulatory.
Expanding the Role of the Pharmacist Enhancing Performance in Primary Care through Implementation of Comprehensive Medication Management.
Medication therapy management
Comments to the FDA on Conditions of Safe Use To Expand Which Drug Products Can Be Considered Nonprescription Marissa Schlaifer, RPh Director of Pharmacy.
HEALTH ECONOMICS BASICS
CONTROLLING THE COSTS OF HEMOPHILIA
Optimizing Meds – Need for Systems Approach
Measuring Outputs, Preparing for Outcomes
3.5 Presenting HPM to Senior Management
Technology & Healthcare in the Middle East
Changing Specialty Distribution to Clinical Management Models
“Next Generation of Connected Health”
Health Information Technology
Comments to the FDA on Conditions of Safe Use To Expand Which Drug Products Can Be Considered Nonprescription Marissa Schlaifer, RPh Director of Pharmacy.
Provider and Member Education in Managed Care Pharmacy
Pharmacy practice and the healthcare system Ola Ali Nassr
Pharmacy – Fully Insured versus Self Funding
Jeff Azevedo President & CEO
Presentation transcript:

Integrate Risk Evaluation & Mitigation Strategies (REMS) with Health Management Craig Kephart, President & CEO Centric Health Resources, Inc. July 15, 2009

Patient Centered Health Management® Risk-Benefit Can We Leverage REMS To Grow The Benefit Number? RISKBENEFIT Lower risk, higher benefit = greater value + greater sales

Patient Centered Health Management® Risk-Cost REMS = Cost Preparation FDA delays Implementation Compliance Evolving FDA guidelines COST MARGIN REVENUE COST MARGIN REVENUE Add to that: price pressure from the growing government payer sector the infrastructure needed to collect data in order to provide measurable outcomes for patients and payers. How do you manage the cost of the REMS? Consider that SPs are great platforms Integrate with an SP Probably most efficient way to handle the REMS

Patient Centered Health Management® REMS Elements and Fit with SPs Safe Access Assure Safe Use Mandatory registry Documentation of patient monitoring Nurse training Technology to collect data lab results, patient health measures Assessments and Monitoring Health management Voluntary patient registry Assessments Therapy compliance and adherence Integrated systems with pharmacy dispensing data Enhance Communications Pharmacist education/counseling 24/7 Clinical support Training Nurse training, education, and clinical services

Patient Centered Health Management® Health outcomes Education, compliance, adherence Therapeutic benefit Looking for Value Health Management More, better decisions By patient and physician, resulting in: Protocol adherence Better health Lower cost Improved Quality of Life

Patient Centered Health Management® Benefit Future – focus on benefit – Why? Mitigate the cost of REMS One platform for REMS, Distribution, & HM = efficiency Use REMS platform to gain additional benefits, such as Higher sales Longer product life cycle Market share Payer acceptance Competitive advantage Ultimately allows you to be prepared for changing reimbursement environment that may include P4P VBBD CE COST MARGIN REVENUE COST MARGIN REVENUE Health Mgmt. Platform

Patient Centered Health Management® CHR Health Management Approach educational and communications interventions: Core Educational Program (LMS) Supplemental specific educational materials Assessments Monitoring Feedback PHC Support behavior change Driven by this holistic, comprehensive support BENEFITS Market differentiation Patient/Physician loyalty and retention Enhanced value proposition to the payer market CHR’s goal is to improve the effectiveness of the patient/physician interaction More, better decisions By patient and physician, resulting in: Protocol adherence Better health Lower cost Improved Quality of Life

Patient Centered Health Management® Health Outcomes Opportunities to drive value beyond therapy Mitigation of co-morbidities Avoid unscheduled HC visits Avoid hospitalizations Avoid ER Higher QOL Productivity Each has an economic value Measure, capture, influence = grows benefit side How do we do that? REMS and HM from one platform = efficiency + additional value “Effects of a Disease Management Program in Patients with Alpha- 1 Antitrypsin Deficiency,” Journal of COPD, Feb. 2009

Patient Centered Health Management® HM and REMS ElementsHMREMS Education/MedGuide Communications Assessments (patient and physician) ETASU Pharmacy & HC provider certification Monitoring Registry Dispensing in certain HC settings Interventions Compliance Adherence to Therapy Patient Relationships Improved Quality of Life HM and REMS Comparison DISTRIBUTION

Patient Centered Health Management® Sell a program not a drug Investor confidence Compliance & Loyalty Comparative Effectiveness P4P VBBD Barriers to competition

Patient Centered Health Management® Summary Companies that are willing to put the right structure in place to monitor patients, collect data, and measure outcomes should find that REMS can work to their advantage. Also an opportunity to capture channel margin to pay for costs, but discussion for later day.